Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients.

Freedman R, Adler LE, Waldo MC, Pachtman E, Franks RD.

Biol Psychiatry. 1983 May;18(5):537-51.

PMID:
6134559
2.

Reduced auditory evoked potential component N100 in schizophrenia--a critical review.

Rosburg T, Boutros NN, Ford JM.

Psychiatry Res. 2008 Dec 15;161(3):259-74. doi: 10.1016/j.psychres.2008.03.017. Epub 2008 Oct 15. Review.

PMID:
18926573
3.

Cognitive event-related potential correlates of schizophrenia.

Pritchard WS.

Psychol Bull. 1986 Jul;100(1):43-66. Review. No abstract available.

PMID:
2874579
4.

The auditory steady-state response (ASSR): a translational biomarker for schizophrenia.

O'Donnell BF, Vohs JL, Krishnan GP, Rass O, Hetrick WP, Morzorati SL.

Suppl Clin Neurophysiol. 2013;62:101-12. Review.

5.

The ageing brain, neuroleptic drugs and the enigma of schizophrenia.

Waddington JL.

Ir J Med Sci. 1988 May;157(5):135-41. Review. No abstract available.

PMID:
2906348
6.

Neurophysiological biomarkers for drug development in schizophrenia.

Javitt DC, Spencer KM, Thaker GK, Winterer G, Hajós M.

Nat Rev Drug Discov. 2008 Jan;7(1):68-83. Review.

Supplemental Content

Support Center